Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
08/2012
08/15/2012EP2313472B1 Azapyrenes for electronic applications
08/15/2012EP2276756B9 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
08/15/2012EP2212323B1 Imidazo [1,2-a] pyridine derivatives useful as alk inhibitors
08/15/2012EP2188283B1 Annelated pyridazines for the treatment of tumors driven by inappropriate hedgehog signalling
08/15/2012EP2170880B1 A process for the preparation of intermediates of tetracyclic compounds
08/15/2012EP2146988B1 New 4,8-diphenyl-polyazanaphthalene derivatives
08/15/2012EP1869060B1 Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof
08/15/2012CN102639533A Azacyclic spiro derivatives
08/15/2012CN102639532A Fused triazole amines as P2X7 modulators
08/15/2012CN102639526A L -dihydro-2-oxoquinoline compounds a 5-ht4 receptor ligands
08/15/2012CN102639499A Processes and intermediates
08/15/2012CN102639152A Manganese chelates and their use as contrast agents in magnetic resonance imaging (MRI)
08/15/2012CN102639132A New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2h)-one derivatives
08/15/2012CN102633798A Method for preparing high-purity matrine from sophora alopecuroides
08/15/2012CN102633797A Purification method of vellosimine
08/15/2012CN102633796A New preparation method of sophora flavescens acid derivative
08/15/2012CN102633795A [4,5-dinitrogen-9-fluorenone] hydrazone compound and method of compound for determining concentration of free cyanide ions in acetonitrile
08/15/2012CN102633794A 5-substituted phenoxy-1, 2, 4-triazole [4, 3-a] pyridine compound used for antiepileptic medicament, and medical salt thereof
08/15/2012CN102633719A Anilino-substituted-methylbenzofuryl quinoline derivatives, and preparation method and application thereof
08/15/2012CN102633716A Bicyclic inhibitors of mek and methods of use thereof
08/15/2012CN102633590A Asymmetrical anthracene derivative and preparation method thereof
08/15/2012CN102631403A Method for preparing total matrines
08/15/2012CN101578284B Agent for improving insulin resistance
08/15/2012CN101489559B Purine and deazapurine derivatives as pharmaceutical compounds
08/15/2012CN101432284B Dihydropyrazolopyrimidinone derivative
08/14/2012US8242275 Bicyclic pyrazole compounds as antibacterial agents
08/14/2012US8242274 Triazolopyridine kinase inhibitors useful for the treatment of degenerative and inflammatory diseases
08/14/2012US8242272 Process for preparing 5-fluoro-1H-pyrazolo [3,4-B] pyridin-3-amine and derivatives thereof
08/14/2012US8242135 Biphenyl derivatives
08/14/2012US8242127 Derivatives of pyrimido[6,1-A]isoquinolin-4-one
08/14/2012US8242125 Heterobicyclic carboxamides as inhibitors for kinases
08/14/2012US8242124 Diketopiperidine derivatives as HIV attachment inhibitors
08/14/2012US8242122 Method and compounds for inhibition of cell death
08/14/2012US8242120 Carbocyclic compounds and methods for treating emerging disease, including influenza and Venezuela equine encephalitis virus
08/14/2012US8242118 Arylsulfonamide derivatives for use as CCR3 antagonists in the treatment of inflammatory and immunological disorders
08/14/2012US8242115 Materials and methods to potentiate cancer treatment
08/09/2012WO2012106499A1 Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
08/09/2012WO2012106495A1 Mesoionic pesticides
08/09/2012WO2012106472A1 Naphthyridine derivatives as inhibitors of hypoxia inducible factor (hif) hydroxylase
08/09/2012WO2012106189A1 Methods of making hiv attachment inhibitor prodrug compound and intermediates
08/09/2012WO2012105629A1 Nitrogenated heterocyclic derivative, electron-transporting material for organic electroluminescent elements, and organic electroluminescent element using same
08/09/2012WO2012105594A1 Ring-fused heterocyclic derivative
08/09/2012WO2012104388A1 New azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors
08/09/2012WO2012103776A1 Naphthacene-5,6:11,12-tetracarboxylic acid diimide compound and preparation method therefor
08/09/2012US20120203003 Continuous Flow Process For The Preparation Of Sulphoxide Compounds
08/09/2012US20120202999 Mapk/erk kinase inhibitors
08/09/2012US20120202997 Materials for organic electroluminescent devices
08/09/2012US20120202927 Preparing and dispersing surface-modified colour pigments
08/09/2012US20120202832 Kinase inhibitors, prodrug forms thereof and their use in therapy
08/09/2012US20120202802 Spirocyclic compounds as modulators of chemokine receptor activity
08/09/2012US20120202800 Dual small molecule inhibitors of cancer and angiogenesis
08/09/2012US20120202791 Tricyclic and Tetracyclic Systems with Activity on the Central Nervous and Vascular Systems
08/09/2012US20120202790 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
08/09/2012US20120202786 Therapeutic isoxazole compounds
08/09/2012US20120202784 Isoindolinone inhibitors of phosphatidylinositol 3-kinase
08/09/2012US20120202783 Fused heterocyclic compounds as orexin receptor modulators
08/09/2012US20120202775 Substituted indole and azaindole oxoacetyl piperazinamide derivatives
08/09/2012US20120202763 Methods for treating cancer and non-neoplastic conditions
08/09/2012US20120202690 Herbicidal compounds
08/09/2012US20120202287 Stem Cell Culture Methods
08/09/2012US20120201816 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
08/09/2012US20120199824 Organic semiconductor material, organic semiconductor thin film, and organic thin film transistor
08/09/2012US20120199044 Preparing and dispersing surface-modified colour pigments
08/09/2012CA2826260A1 Methods of making hiv attachment inhibitor prodrug compound and intermediates
08/09/2012CA2826051A1 7-azaindole derivatives
08/09/2012CA2825279A1 New azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors
08/09/2012CA2825204A1 Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
08/08/2012EP2484679A2 N3-heteroaryl substituted triazoles and n5-heteroaryl substitued triazoles useful as axl inhibitors
08/08/2012EP2483275A1 HETEROCYCLIC-FUSED PYRAZOLO[4,3-c]PYRIDIN-3-ONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS
08/08/2012EP2483271A1 Pyrazoline dione derivatives as nadph oxidase inhibitors
08/08/2012EP2483268A1 Pyridinyl-imidazolone derivatives for inhibiting pi3 kinases
08/08/2012EP2483255A1 Oxazine derivatives and their use in the treatment of neurological disorders
08/08/2012EP2483245A1 Condensed ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (s1p2) receptors
08/08/2012EP2482819A2 Combination
08/08/2012EP2200612B1 Inhibitors of janus kinases
08/08/2012EP1831226B1 Chiral tetracyclic compounds inducing interferon biosynthesis
08/08/2012EP1831221B1 Substituted chiral fused 1,2 imidazo 4,5-c ring compounds
08/08/2012EP1601674B1 Hydroxyalkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
08/08/2012EP1169038B1 Cyclic protein tyrosine kinase inhibitors
08/08/2012CN102627657A Synthetic method of 3-(4-methoxy-benzyl)-1H-pyrimidine-2,4-dione derivative
08/08/2012CN102627649A Small molecule inhibitors of MDM2 and uses thereof
08/08/2012CN102627642A Metal complexes of moxifloxacin and pharmaceutical purpose thereof
08/08/2012CN102285985B Preparation method of 10-hydroxyl praziquantel and application thereof as anti-schistosomiasis medicine
08/08/2012CN101921229B Synthesis method of stepholidine or derivative optical isomer thereof and intermediate thereof
08/08/2012CN101870695B Preparation method of 3-(2-chloroethyl)-6, 7, 8, 9 - tetrahydro-9 - hydroxy - 2 - Methylenetetrahydrofolate - pyrido [1,2-alpha] pyrimidine -4 - ketone
08/08/2012CN101384604B Ethanol or 1,2-ethanediol cyclohexyl antibiotic derivatives
08/08/2012CN101310771B 视觉功能障碍改善剂 Visual dysfunction improving agent
08/08/2012CN101022728B Imidazole compounds
08/07/2012US8236965 Benzimidazole derivatives and their use as a medicament
08/07/2012US8236818 Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists
08/07/2012US8236817 Polymorphs of 1-cyclopropy1-7-([s,s])-2,8-diazadicyclo[4.3.0]non-8-yl)-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinoline carboxylic acid hydrochloride and methods for the preparation thereof
08/07/2012US8236813 Tricyclic pyrazolopyrimidine derivatives
08/07/2012US8236800 antimicrobial agents and antidote for hemorrhagic complications associated with heparin therapy; peptide having optimal sites of polar and nonpolar substituents that confer amphiphilic properties; leucine and aminobenzoic acid derivative; isophthalic acid and diaminobenzene, 3-tert-butyl-6-alkylthio cmpd
08/07/2012US8236793 Diazabicyclic aryl derivatives as cholinergic receptor modulators
08/07/2012CA2438314C 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
08/02/2012WO2012102583A1 Pharmaceutical composition comprising pyridone derivatives
08/02/2012WO2012102580A1 Pharmaceutical composition comprising pyridone derivatives
08/02/2012WO2012102297A1 Pyrazolopyridine derivative or pharmacologically acceptable salt thereof
08/02/2012WO2012101487A1 Di/tri-aza-spiro-c9-c11alkanes
08/02/2012WO2012101453A1 Protease activated receptor 2 (par2) antagonists
1 ... 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 ... 646